ABSTRACT A stable free-radical polymeric derivative of prostaglandin B1 (PGBX) has been synthesized that exhibits regenerative effects on oxidative phosphorylation in aged mitochondria. The molecular weights of the most active preparations fall between 2000 (12) to obtain 4.1 g of 9,15-diketo-methyl ester of PGBI. For the conversion to PGBX, 3 g of diketo-methyl ester of PGB1 was dissolved in 60 ml of ethanol, and KOH was added to a final concentration of 1 M. This solution was heated at 80°C for 4 hr and then cooled to room temperature. Equal volumes of isobutanol and water (120 ml each) were added and the solution was adjusted to pH 3 with addition of 2.3 M perchloric acid. The precipitate that formed was allowed to settle. The supernatant was decanted and the precipitate discarded. The red isobutanol layer was washed twice with water and finally extracted into 0.1 M NaHCO3. The NaHCO3 layer, which contained most of the active components, was acidified to pH 3 and shaken with isobutanol. The isobutanol layer was washed free of salts and evaporated under reduced pressure. The active PGBX was isolated from this mixture by molecular exclusion chromatography on Sephadex LH20 in methanol. Because of the low chromatographic capacity of the LH20, only 1-2 g of PGBX could be chromatographed at a time on a 95 X 5 cm column. The separation was followed by monitoring of UV absorption at 280 nm and the refractive index. About 0.54 g of active PGBX was obtained from the original 3 g of diketo-methyl ester of PGB1.
ABSTRACT A stable free-radical polymeric derivative of prostaglandin B1 (PGBX) has been synthesized that exhibits regenerative effects on oxidative phosphorylation in aged mitochondria. The molecular weights of the most active preparations fall between 2000 and 2600. PGBX is characterized by a singleline electron spin resonance spectrum that is stable at room temperature. PGB, restores phosphorylating ability and net ATP synthesis in isolated mitochondria aged for 4 days at 00C and protects against further degradation of phosphorylating activity when such aged mitochondria are preincubated at 280C in the absence of adenine nucleotide phosphate acceptors. This compound has been reported to exert beneficial effects in vivo in experimental pathological conditions, such as regional ischemia, in which the mitochondria of the ischemic region may have been damaged. Mitochondria freshly isolated from rat liver by the method of Hogeboom et al. exhibit maximal oxidative phosphorylation approaching a P:O ratio of 3 with substrate of NAD+-linked dehydrogenases (1) . When stored at 0°C, these mitochondria slowly uncouple oxidation from phosphorylation, resulting in a progressive P:O decrement (2) (3) (4) . Addition of serum albumin to test mixtures containing these aged mitochondria restores the coupled reaction so that the P:O again approaches 3.0 (5) . By exposure of aged mitochondria to 28°C for 5-20 min, a further uncoupling of oxidative phosphorylation results. This is not affected by further additions of serum albumin.f In an attempt to reverse or protect against this latter uncoupling, a number of substances were tested. Preliminary tests showed that a partial preservation could be obtained with prostaglandin E1 and prostaglandin B1 (PGB1) added to the test mixture during the 28°C degradation step (6) . Studies were therefore undertaken to investigate other prostaglandins and prostaglandin derivatives that might be more effective in restoring oxidative phosphorylation in vitro (7) . The best results to date have been obtained with a compound termed PGBX, prepared in this laboratory and derived from PGBI. PGBX also exhibits dramatic physiological restorative effects on surgically induced ischemic heart (8) and ischemic brain in animals (9) and normalizes some of the clinical derangements in genetically diabetic mice (10) . This report describes the preparation of PGBX and its effects on the preservation and restoration of oxidative phosphorylation in degraded mitochondria.
METHODS
Preparation of PGBX. Crystalline PGB1 (4.4 g) (prepared by George Nelson, St. Joseph's College, Philadelphia, PA) was methylated by treatment with diazomethane (11) followed by oxidation with Jones reagent (12) to obtain 4.1 g of 9,15-diketo-methyl ester of PGBI. For the conversion to PGBX, 3 g of diketo-methyl ester of PGB1 was dissolved in 60 ml of ethanol, and KOH was added to a final concentration of 1 M. This solution was heated at 80°C for 4 hr and then cooled to room temperature. Equal volumes of isobutanol and water (120 ml each) were added and the solution was adjusted to pH 3 with addition of 2.3 M perchloric acid. The precipitate that formed was allowed to settle. The supernatant was decanted and the precipitate discarded. The red isobutanol layer was washed twice with water and finally extracted into 0.1 M NaHCO3. The NaHCO3 layer, which contained most of the active components, was acidified to pH 3 and shaken with isobutanol. The isobutanol layer was washed free of salts and evaporated under reduced pressure. The active PGBX was isolated from this mixture by molecular exclusion chromatography on Sephadex LH20 in methanol. Because of the low chromatographic capacity of the LH20, only 1-2 g of PGBX could be chromatographed at a time on a 95 X 5 cm column. The separation was followed by monitoring of UV absorption at 280 nm and the refractive index. About 0.54 g of active PGBX was obtained from the original 3 g of diketo-methyl ester of PGB1.
Isolation of Rat Liver Mitochondria. A modification of the procedure of Hogeboom et al. (1) , summarized below, was used. Rats were decapitated and their livers were excised as rapidly as possible and washed with ice-cold 0.3 M sucrose (enzyme grade) containing 0.5 mM EDTA (pH 7.35). The livers were homogenized (glass barrel, Teflon pestle) in the same solution, and the mitochondria were separated by differential centrifugation. The nuclei were sedimented at 1000 X g for 15 min. The yield of mitochondria could be increased by rehomogenizing the nuclei in 3 vol of sucrose/EDTA and centrifuging again at 1000 X g. The 1000 X g supernatant layers were combined and centrifuged at 10,000 X g for 15 min to sediment the mitochondria. The pellet was homogenized and recentrifuged at 6000 X g and again at 4000 X g. The supernatant layers from both the 10,000 X g and 6000 X g centrifugations were removed by aspiration, while the 4000 X g supernatant layer was decanted completely to remove the "fluffy layer." To increase the yield of mitochondria, we homogenized the fluffy layer with 2 vol of sucrose/EDTA and centrifuged the mixture at 6000 X g. The 6000 X g supernatant layer was decanted; the pellets from both the 4000 X g and 6000 X g centrifugations were homogenized in sucrose/EDTA and centrifuged at 600 X g to separate any cellular debris or nuclei that might still be present. The volume of mitochondrial suspension was adjusted to 100 mg of protein per ml and the preparation was stored at 0°C until used. Usually 1.3 g of mitochondria were obtained from 100 g of rat liver. 
Assay of Effects of PGBX on Mitochondrial Oxidative
Phosphorylation. The PGBX activation of initochondki *q dative phosphorylation may be demonstrated by first aging the mitochondria at 00C for at least 3 days and then degrading oxidative phosphorylation further by incubation at 280C in the absence of phosphate acceptor (ADP). Because the degree of degradation required varies with each mitochondrial preparation and with the time of storage, the preliminary incubation was varied to determine the time needed to reach the 90-95% degradation of phosphorylating activity. For this purpose, a portion of aged mitochondria was diluted with cold distilled water and centrifuged at 6000 X g. The supernatant fluid was removed, an equivalent volume of 0.15 M sucrose/0.25 mM EDTA was added, and the mitochondria were suspended by gentle mechanical mixing. The optimal degradation time was determined by addition of mitochondria (4 mg of protein) to 10-ml beakers containing 0.1 ml of 0.1 M potassium phosphate (pH 7.35), 0.15 ml of 0.2 M a-ketoglutarate (pH 7.35), 0.1 ml of 0.1 M MgSO4, and water to a total volume of 2.01 ml. The beakers were covered and shaken at 280C for 5, 10, 15, and 20 min. At the end of each time period, 0.15 ml of a mixture containing 33.3 mM ADP, 33.3 mM AMP, and 667 mM KC1 was added, followed immediately with 0.04 ml of 3.75% bovine serum albumin to achieve a final volume of 2.2 ml. The shaking was then continued for 20 min, during which time phosphate esterification took place. The reaction was terminated by the addition of 0.5 ml of 31% HC104. The inorganic phosphate concentration was then determined in the protein-free filtrate by the method of Dreisbach (13) . The phosphate esterified was calculated by difference from the phosphate concentration found in each reaction beaker to one in which perchloric acid was added prior to the addition of the mitochondria. The required degradation time was chosen as the minimum time required to reduce the level of phosphorylation to less than 5% of the maximum. Having established the conditions for mitochondrial degeneration to near zero phosphorylation, the PGB, effect could then be shown by adding various amounts of PGB, (i.e., 2, 4, 6, and 8 ,ug) during the predetermined preincubation period prior to the addition of inorganic phosphate and phosphate acceptor.
The degree of preservation of phosphorylation in degraded mitochondria by PGBx is concentration dependent. The relationship, however, is not linear, but rather sigmoid, and could not readily be described by any mathematical equation. Therefore, in order to compare PGB, preparations at various stages of purification, we designated the most active fraction the standard and arbitrarily assigned its activity a relative value of 100%. Other preparations could then be compared by simultaneously determining the dose-response curves of the standard and unknown PGBx preparations at the same concentrations. PGBx activity was then expressed in terms of per- (Fig. IA) . A distinguishing physical property of PGBX is its single-line electron spin resonance (ESR) spectrum (Fig. 1B) , which is stable at room temperature. The absence of any fine structure in the ESR spectrum might be interpreted as the result of a delocalized, resonance-stabilized, unpaired electron structure. The relationship between molecular weight and activity of PGBX preparations in Fig. 1C shows that the activity is distributed over a range of molecular weights between 500 and 5000, with an optimum between 2000 Fig. 2A) . If PGBx was included in the preincubation mixtures, the mitochondria retained their full phosphorylating ability. Mitochondria stored as concentrated suspensions in sucrose/EDTA at 00C gradually lose phosphorylating ability over a period of 3-8 days, which is manifested by a more severe loss of phosphorylation with shorter incubation times. In 4-day-old mitochondria, phosphorylation declined to undetectable levels within 5-10 min of preincubation (Fig. 2B) . When mitochondria were preincubated in the presence of PGBX, the high level of phosphorylation was maintained. PGBX has no apparent effects on undamaged mitochondria, but has maximal protective effects with mitochondria damaged to the extent of approximately 90-95% loss of oxidative phosphorylating activity.
The protective effect of PGBx on the phosphorylation of mitochondria aged for 4 days at 0°C and then preincubated for 7 min in the absence of phosphate acceptor is shown in Fig. 2C (10 ,ug) in the preincubation mixture. (C) PGBX concentration dependence of the mitochondrial phosphorylation protection effect. Four-day-old mitochondria were preincubated for 7 min with different amounts of PGBX (0-9 jg) in the preincubation mixture.
phorylation (15, 16) . The data in Fig. 3A show that mitochondrial phosphorylation decreases with increasing concentrations of Ca2+. The addition of PGBX prevents the Ca2+ inhibition of mitochondrial phosphorylation. This competition between Ca2+ and PGBX for direction of oxidative energy, as seen here, suggests that an in vitro mechanism is available for the control of phosphorylation in mitochondria.
PGBX also prevents inhibition of mitochondrial phosphorylation by dinitrophenol (Dnp) (Fig. 3B) . At low concentrations of Dnp, there seem to be synergistic actions of PGBX and Dnp, with a stimulation of phosphorylation above the level of phosphorylation seen with PGBX alone. At higher concentrations of Dnp, there is a progressive decrease in phosphorylation until it reaches negligible levels. generated to the point of having lost almost all net phosphorylation ability, PGBX added to the reaction restores this activity. The data implicate PGBX in energy-transfer mechanisms across mitochondrial membranes and offer a new approach to reactivation of oxidative phosphorylation. The mechanisms of action of PGBX in these processes are unclear. It may involve the participation of PGBX free radicals in the conservation of the energy from electron transport in the synthesis of high-energy phosphate bonds. Another possibility would be the involvement of a prostaglandin-type of compound in mitochondrial function. The elucidation of the true mechanism of PGBX action can probably only be solved by further study of oxidative phosphorylation and of the structure and chemical properties of PGBX.
While the present studies concern isolated mitochondria in vitro, a number of protective and restorative effects of PGBX have been observed in viwo in animals in a variety of experimentally induced diseased states. PGBX facilitates and significantly increases survival after what otherwise would be lethal episodes of myocardial infarction with fibrillation in monkeys (8) and after acute complete cerebral ischemia of 20-min duration in rabbits (9) . Presumably these contributions to survival are attributable to the ability of PGBX to reactivate damaged mitochondria in the affected tissues. In vivo effects of PGBX on phospholipid metabolism have also been demonstrated (17) . Finally, PGBX has also been found to normalize the high blood glucose and the obesity in hereditary diabetic mice (10) .
PGBX may therefore represent a new class of polymeric lipid bioregulatory factors with unique effects on energy transfer mechanisms across biological membranes in vitro and implied interactions with hormonal factors in vivo.
